Vetoquinol announced that Felpreva® is now available for veterinarians to prescribe in five European markets including France, Germany, United Kingdom, Austria and Italy. Felpreva® is an innovation in companion animal parasitology. It is the first three-monthly spot-on parasiticide for cats that covers tapeworms in addition to other endoparasites (lungworms, roundworms and hookworm) and ectoparasites (fleas, ticks and mites) in a single dose.

It is licensed for treatment of cats with, or at risk from, mixed parasitic infestations/infections. Felpreva®'s broad-spectrum active ingredients cover: Endoparasites: Gastrointestinal roundworms: infection with Toxocara cati, Toxascaris leonina and Ancylostoma tubaeforme, Lungworms: infection with Aelurostrongylus abstrusus and Troglostrongylus brevior, Tapeworms: infection with Dipylidium caninum and Taenia taeniaeformis. Ectoparasites: Flea (Ctenocephalides felis), tick (Ixodes ricinus, Ixodes holocyclus) and mite (Otodectes cynotis) infestations, as well as mild to moderate cases of notoedric mange (caused by Notoedres cati).

It can also form part of a treatment strategy for flea allergic dermatitis (FAD). A recent survey revealed that 44% of cat owners said that giving parasite protection to their cat was a negative experience.2 Therefore reducing the frequency of treatments, Felpreva®, will also reduce stressful interactions between cats and their owners, and will result in a more positive experience for all, with the ultimate goal to increase compliance and thus improve parasite protection for cats.